[{“box”:0,”content”:”n[if 992 equals=”Open Access”]n
n
Open Access
nn
n
n[/if 992]n[if 2704 equals=”Yes”]n
nThis is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.n
n[/if 2704]n
n
n
nn
n
Sanjana V Rao,
n t
n
n[/foreach]
n
n[if 2099 not_equal=”Yes”]n
- [foreach 286] [if 1175 not_equal=””]n t
- Student, Department of Biotechnology, BMS College of Engineering, Bengaluru, Karnataka, India
n[/if 1175][/foreach]
n[/if 2099][if 2099 equals=”Yes”][/if 2099]n
Abstract
n
n
nMenstrual disorders, including dysmenorrhea (painful menstruation), amenorrhea (absence of
menstruation), and irregular menstrual cycles, significantly impact women reproductive health
and overall well-being. These conditions often arise from hormonal imbalances, inflammation, and
uterine dysfunction, necessitating effective therapeutic interventions. Current treatments, such as
hormonal therapies (oral contraceptives, progestin-only pills), NSAIDs, and surgical procedures
(endometrial ablation, hysterectomy), provide relief but often target symptoms rather than
addressing the underlying causes. Consequently, there is a growing interest in alternative plant-based therapies with gynecological benefits, with Abroma augusta emerging as a promising candidate. The objective of the study is to identify the potential phytocompounds of Abroma
augusta and evaluate their therapeutic potential by analyzing their binding affinity with Estrogen
Receptor Alpha (ER-α) through molecular docking. By investigating the molecular interactions of
these compounds, this research seeks to provide scientific validation for the traditional use of A.
augusta and explore its potential as a natural therapeutic agent for menstrual disorders.nn
n
Keywords: Menstrual disorders, Abroma augusta, Estrogen Receptor Alpha (ER-α), Molecular Docking
n[if 424 equals=”Regular Issue”][This article belongs to International Journal of Molecular Biotechnological Research ]
n
n
n
n
nSanjana V Rao. [if 2584 equals=”][226 wpautop=0 striphtml=1][else]MOLECULAR DOCKING OF ABROMA AUGUSTA PHYTOCOMPOUNDS AGAINST ESTROGEN RECEPTOR ALPHA (ER-α) FOR THE TREATMENT OF MENSTRUAL DISORDERS[/if 2584]. International Journal of Molecular Biotechnological Research. 16/09/2025; 03(02):-.
n
nSanjana V Rao. [if 2584 equals=”][226 striphtml=1][else]MOLECULAR DOCKING OF ABROMA AUGUSTA PHYTOCOMPOUNDS AGAINST ESTROGEN RECEPTOR ALPHA (ER-α) FOR THE TREATMENT OF MENSTRUAL DISORDERS[/if 2584]. International Journal of Molecular Biotechnological Research. 16/09/2025; 03(02):-. Available from: https://journals.stmjournals.com/ijmbr/article=16/09/2025/view=0
nn
n
n[if 992 not_equal=”Open Access”]n
n
n[/if 992]n
nn
Browse Figures
n
n
n[/if 379]
n
n
n
References n
n[if 1104 equals=””]n
- Goswami R, Chatterjee P, Sinha T. Abroma augusta (L.) L. f.: An ethnopharmacological
review of its traditional uses and modern applications. World J Biol Pharm Health Sci.
2023;14(3). doi:10.30574/wjbphs.2023.14.3.0235.
2. Hazra K, Dutta S, Mandal AK, Ravte RK, Mitra A, Hazra J. Pharmacognostical and
phytochemical blueprint of Abroma augusta L. stem bark. Indian J Nat Prod Res.
2021;12(2):271–280.
3. Balkrishna A, Mishra S, Dhyani A, Saini P, Arya V, Sharma N. A comprehensive review of
Abroma Augusta (Devil’s Cotton): Phytochemical constituents, ethnomedicinal
applications, and pharmacological properties. Curr Indian Sci. 2023.
4. Marjhan N. Review on therapeutic properties of Abroma Augusta L. 2024;10:42–45.
5. Soundarmal JK, Tupkar SD, Biyani KR, Ruptakke SM. A review of the phytochemical
constituents and pharmacological activities of Abroma augusta Linn. World J Pharm Res.
2023;12(5):589–594. doi:10.20959/wjpr20235‑27558
6. Tang ZR, Zhang R, Lian ZX, Deng SL, Yu K. Estrogen-receptor expression and function in
female reproductive disease. Cells. 2019;8(10):1123. doi:10.3390/cells8101123.
7. Chen P, Li B, Ou-Yang L. Role of estrogen receptors in health and disease. Front
Endocrinol (Lausanne). 2022;13:839005. doi:10.3389/fendo.2022.839005.
8. Arnal JF, Lenfant F, Metivier R, Flouriot G, Henrion D, Adlanmerini M, et al. Membrane
and nuclear estrogen receptor alpha actions: From tissue specificity to medical implications.
Physiol Rev. 2017;97(3):1045–1087. doi:10.1152/physrev.00024.2016.
9. Enmark E, Pelto-Huikko M, Grandien K, Lagercrantz S, Lagercrantz J, Fried G, et al.
Human estrogen receptor beta-gene structure, chromosomal localization, and expression
pattern. J Clin Endocrinol Metab. 1997;82(12):4258–4265. doi:10.1210/jcem.82.12.4470.
10. Jia M, Dahlman-Wright K, Gustafsson JÅ. Estrogen receptor alpha and beta in health and
disease. Best Pract Res Clin Endocrinol Metab. 2015;29(4):557–568.
doi:10.1016/j.beem.2015.04.008.
11. Yu K, Huang ZY, Xu XL, Li J, Fu XW, Deng SL. Estrogen receptor function: Impact on the
human endometrium. Front Endocrinol (Lausanne). 2022;13:827724.
doi:10.3389/fendo.2022.827724.
12. Mohanraj K, Karthikeyan BS, Vivek-Ananth RP, Chand RPB, Aparna SR, Mangalapandi P,
et al. IMPPAT: A curated database of Indian medicinal plants, phytochemistry and
therapeutics. Sci Rep. 2018;8(1):4329. doi:10.1038/s41598-018-22631-z.
13. Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, et al. PubChem in 2021: New data
content and improved web interfaces. Nucleic Acids Res. 2021;49(D1):D1388–D1395.
doi:10.1093/nar/gkaa971.
14. Burley SK, Berman HM, Kleywegt GJ, Markley JL, Nakamura H, Velankar S. Protein Data
Bank (PDB): The single global macromolecular structure archive. Methods Mol Biol.
2017;1607:627–641. doi:10.1007/978-1-4939-7000-1_26.
15. Jejurikar BL, Rohane SH. Drug designing in Discovery Studio. Asian J Res Chem.
2021;14(2):135–138. doi:10.5958/0974-4150.2021.00025.0.
16. Zhou AQ, O’Hern CS, Regan L. Revisiting the Ramachandran plot from a new angle.
Protein Sci. 2011;20(7):1166–1171. doi:10.1002/pro.644.
17. Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate
pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.
Sci Rep. 2017;7:42717. doi:10.1038/srep42717.
18. Yang H, Lou C, Sun L, Li J, Cai Y, Wang Z, et al. admetSAR 2.0: Web-service for
prediction and optimization of chemical ADMET properties. Bioinformatics.
2019;35(6):1067–1069. doi:10.1093/bioinformatics/bty707.
19. Kondapuram S, Sarvagalla S, Coumar M. Docking-based virtual screening using PyRx tool:
Autophagy target Vps34 as a case study. In: Computational Approaches in Drug Discovery
and Precision Medicine. 2021. doi:10.1016/B978-0-12-822312-3.00019-9.
20. Alam M, Ahmed S, Elasbali AM, Adnan M, Alam S, Hassan MI, et al. Therapeutic
implications of caffeic acid in cancer and neurological diseases. Front Oncol.
2022;12:860508. doi:10.3389/fonc.2022.860508.
21. Pavlíková N. Caffeic acid and diseases—Mechanisms of action. Int J Mol Sci.
2022;24(1):588. doi:10.3390/ijms24010588.
22. Gulati M, Singh S, Kuppusamy G, Kapoor B, Mishra V, Gupta S, et al. Discovering
multifaceted role of vanillic acid beyond flavours: Nutraceutical and therapeutic potential.
Trends Food Sci Technol. 2022;122:10–23. doi:10.1016/j.tifs.2022.02.023.
23. Kakkar S, Bais S. A review on protocatechuic acid and its pharmacological potential. ISRN
Pharmacol. 2014;2014:952943. doi:10.1155/2014/952943.
24. Gupta B, Nayak S, Solanki S. Abroma augusta Linn f: a review. Der Pharmacia Sinica.
2011;2(4):253–261
25. Rahman AHMM. Ethno-gynecological study of traditional medicinal plants used by Santals
of Joypurhat district, Bangladesh. Biomed Biotechnol. 2014;2(1):10–13.
nn[/if 1104][if 1104 not_equal=””]n
- [foreach 1102]n t
- [if 1106 equals=””], [/if 1106][if 1106 not_equal=””],[/if 1106]
n[/foreach]
n[/if 1104]
n
nn[if 1114 equals=”Yes”]n
n[/if 1114]
n
n

n
International Journal of Molecular Biotechnological Research
n
n
n
n
nn
n
| Volume | 03 | |
| [if 424 equals=”Regular Issue”]Issue[/if 424][if 424 equals=”Special Issue”]Special Issue[/if 424] [if 424 equals=”Conference”][/if 424] | 02 | |
| Received | 17/05/2025 | |
| Accepted | 18/06/2025 | |
| Published | 16/09/2025 | |
| Retracted | ||
| Publication Time | 122 Days |
n
n
nn
n
Login
PlumX Metrics
n
n
n[if 1746 equals=”Retracted”]n
[/if 1746]nnn
nnn”}]